Higher HDR prostate D90 did not improve long-term biochemical control once coverage was adequate
Across 286 HDR monotherapy patients, higher EQD2 D90 was not associated with biochemical control or overall survival.
Across 286 HDR monotherapy patients, higher EQD2 D90 was not associated with biochemical control or overall survival.
In 607 predominantly high-risk patients, 15 Gy HDR boost plus EBRT produced durable six-year disease control with low severe late toxicity.
Motorized probe rotation improved sagittal 3D ultrasound consistency and eliminated significant inter-operator variability seen with manual acquisition.
Grade ≥2 GI toxicity was 14% with oART versus 45% with IGRT, with better preservation of several HRQoL domains.
A deep-learning model ordered first-to-last fraction images with 95% accuracy, while smaller longitudinal changes were associated with later biochemical recurrence.
Two prostate RT cases suggest that focal lumbosacral plexus hotspots, particularly near 70 Gy, may contribute to severe neurologic toxicity.
In one macroscopic recurrence abutting rectum, an endorectal balloon reduced rectal V75 from 24.6% to 8.6%, enabling a 78 Gy boost.
Each one-point increase in baseline IPSS independently increased the odds of late grade ≥2 GU toxicity by 11%.
After propensity matching, five-year PSA recurrence-free survival was 94.5% with 36.25 Gy versus 93.2% with 40 Gy.
After a national audit triggered pathway redesign, severe late GI toxicity after prostate EBRT fell from 16% to 7.5%.
Bladder diameter >10 cm at simulation was associated with longer fractions, more interruptions and greater patient frustration during prostate RT.
In 223 previously irradiated patients, 3×10 Gy and 2×13 Gy salvage HDR brachytherapy produced similar disease control and late toxicity.
AI pelvic nodal contours achieved a Dice score of 0.79 on withheld prostate RT cases but retained localized boundary disagreements.
Among 88 patients receiving both treatments, PSA50 response was 55.7% and prior metastasis-directed EBRT did not increase hematologic toxicity.
PET-directed elective nodal RT plus temporary ADT yielded 77% 10-year overall survival with low grade 3 GU and GI toxicity.